Speaker illustration

Mr Martin Longhi Engelbrecht

Gentofte University Hospital, Gentofte (Denmark)

Five-year risk of death and readmission for heart failure after implantation of de novo and upgrade cardiac resynchronization therapy devices

Event: ESC Congress 2019

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: CRT: specific populations and novel imaging techniques of cardiac mechanics


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb